Disbandment. The procedures for disbanding a Department or Chapter that are contained in the National Bylaws must be followed if Department or Chapter wishes to disband. The Department or Chapter must file with the I.R.S., a final 990, before they are approved to disband.
Disbandment. Upon the **** anniversary of the Effective Date, the JDC shall have no further responsibilities or authority under this Agreement and will be considered dissolved by the Parties.
Disbandment. The JDC shall remain in effect from the date on which it is established in accordance with Section 3.1 until, on a Research Program-by-Research Program basis, the expiration of the applicable Research Term.
Disbandment. The JSC shall continue to exist until the first to occur of (a) the Parties mutually agreeing to disband the JSC and (b) completion of the Research Collaboration Term (unless otherwise mutually agreed in writing). Notwithstanding anything herein to the contrary, upon the first to occur of the foregoing (a) or (b), the JSC shall automatically dissolve and shall have no further rights or obligations under this Agreement, and thereafter (i) each Party shall designate, to the extent necessary, a contact person for the exchange of Information under this Agreement or such exchange of Information shall be made through the Alliance Managers, and (ii) decisions of the JSC, if any, shall be decisions as between the Parties, subject to the other terms and conditions of this Agreement. For clarity, the Patent Working Group shall survive dissolution of the JSC until such time as the Parties mutually agree to disband it.
Disbandment. Upon Marketing Authorization of the Product in all countries of the Territory, unless otherwise mutually agreed in writing, the JSC shall have no further responsibilities or authority under this Agreement and will be considered dissolved by the Parties.
Disbandment. Upon Regulatory Approval of the last Licensed Product developed pursuant to the Development Plan and Budget, unless otherwise mutually agreed in writing, the JDC shall have no further responsibilities or authority under this Agreement and will be considered dissolved by the Parties. Additionally, in the event of a Change in Control of Galapagos, Xxxxxx shall have the right at any time and for any reason, effective upon written notice, to disband the JDC pursuant to Section 13.2.2.
Disbandment. 22.01 In the event that the municipal council requests that the police service governed by this collective agreement be disbanded, the parties agree that they shall meet together and negotiate, in good faith, concerning issues of concern arising from disbandment. These negotiations shall be without prejudice to the position of either party concerning any issues.
22.02 The parties agree that the issues to be negotiated may include, but are not limited to:
(a) costs, if any, relating to transfers or pensions;
(b) severance arrangements for members not offered employment by the Ontario Provincial Police;
(c) provisions dealing with members who are absent from duty by virtue of illness or injury;
(d) provisions dealing with the continuation of existing rights of retired members.
22.03 The parties agree that nothing in this Article shall prejudice their rights under Section 40 of the Police Services Act.
Disbandment. Upon Regulatory Approval of the last Licensed Product developed pursuant to a Collaboration Development Plan and Budget, unless otherwise mutually agreed in writing, the JDC shall have no further responsibilities or authority under the Collaboration Agreement and shall be considered dissolved by the Parties.
Disbandment. Upon expiration of the RA Review Period and the SLE Review Period without AbbVie proceeding with the In-Licensing, the JSC shall have no further responsibilities or authority under this Agreement and will be considered dissolved by the Parties. Additionally, in the event of a Change in Control of Ablynx, AbbVie shall have the right at any time and for any reason, effective upon written notice, to disband the JSC pursuant to Section 13.2.2.
Disbandment. Upon (i) expiration of the RA Review Period and the SLE Review Period without AbbVie proceeding with the In-Licensing, or (ii) Regulatory Approval of the last Licensed Product developed pursuant to a Development Plan, unless otherwise mutually agreed in writing, the JDC shall have no further responsibilities or authority under this Agreement and will be considered dissolved by the Parties. Additionally, in the event of a Change in Control of Ablynx, AbbVie shall have the right at any time and for any reason, effective upon written notice, to disband the JDC pursuant to Section 13.2.2.
